Best Undervalued Stocks To Own Right Now

tags:LIQT,MYOK,CSIQ,

We initiate a BUY rating on ATN International, Inc. (NASDAQ:ATNI), and our target price is $74.9. ATNI is an expanding company investing worldwide both in telecommunications and renewable energy industries. Its international and multi-industrial investing strategies successfully overcome the decline in U.S. telecommunications business, which ensures a stable growth rate for the company. The stable growth and strong financial capability in turn enable the company for further investments. Overall, we think the stock price is currently undervalued.

Company Highlights

(1) ATNI has made two acquisitions to strengthen its presence in the Caribbean and has started a large-scale solar project in India. These new ventures should enable the company to generate a new source of free cash flow after its prediction of breakeven by the first half of 2017.

(2) The U.S. telecom segment is shrinking due to lower wholesale roaming data rate, partially offset by an increase in data volume. We don't see rapid growth in this segment.

Best Undervalued Stocks To Own Right Now: LiqTech International, Inc.(LIQT)

Advisors' Opinion:

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss. Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results. Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88. Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results. SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results. Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat. Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results. LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results. ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results. Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. MYnd
• [By Money Morning Staff Reports]

  But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we'll show you a small-cap stock with great profit potential in its future…

  Penny Stock Current Share Price Law Month's Gain �Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85% Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40% Vivis Inc. (Nasdaq: VVUS) $0.77 150.41% Adomani Inc. (Nasdaq: ADOM) $1.49 137.68% NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88% Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06% Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12% ArQule Inc. (Nasdaq: ARQL) $4.88 90.74% LiqTech International Inc. (NYSE: LIQT) $0.66 85.60% Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

  While last month's gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

• [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close

Best Undervalued Stocks To Own Right Now: MyoKardia, Inc.(MYOK)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on MyoKardia (MYOK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Shares of Myokardia Inc (NASDAQ:MYOK) have been assigned an average recommendation of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $69.50.

Best Undervalued Stocks To Own Right Now: Canadian Solar Inc.(CSIQ)

Advisors' Opinion:

• [By Shane Hupp]

  These are some of the news stories that may have impacted Accern’s scoring:

  Get Canadian Solar alerts: Global PV (Photovoltaics) Market Emerging Technology by 2023: Jinko Solar, Canadian Solar, Trina Solar and Hanwha (thecleantechnology.com) $715.14 Million in Sales Expected for Canadian Solar (CSIQ) This Quarter (americanbankingnews.com) Canadian Solar (CSIQ) Expected to Announce Earnings of $0.44 Per Share (americanbankingnews.com) EGEB: 2 offshore wind mega-projects awarded on East coast, Trump��s tariffs hit Canadian Solar, last call for cheapest upgraded turbines (electrek.co) Short Sellers Still Cool to Solar Stocks, Betting Against Alt Energy (msn.com)

  NASDAQ:CSIQ traded down $0.27 during trading hours on Thursday, reaching $16.62. 8,992 shares of the company’s stock were exchanged, compared to its average volume of 564,562. The stock has a market cap of $982.57 million, a P/E ratio of 16.00, a P/E/G ratio of 0.32 and a beta of 2.58. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.94 and a quick ratio of 0.83. Canadian Solar has a 1-year low of $12.24 and a 1-year high of $19.09.

• [By Paul Ausick]

  Canadian Solar Inc. (NASDAQ: CSIQ) saw a decrease of 16.6% in short interest during the two-week period. Some 3.3% of the total float, or 1.49 million shares, were short and days to cover remained unchanged at three. The company’s share price fell by about 5.4% over the two weeks, and shares closed Wednesday at $16.26, up about 3.4% for the day, in a 52-week range of $12.07 to $19.09.

• [By Dan Caplinger]

  Wall Street enjoyed a positive session on Monday, with highlights including strong gains for most major benchmarks. Investors found it easier to be optimistic about the prospects for continued economic growth than to be pessimistic about the potential negative outcomes of recent trade disputes between the U.S. and key allies. Even so, some companies had to deal with bad news that hurt them disproportionately and sent their shares lower. Canadian Solar (NASDAQ:CSIQ), Nektar Therapeutics (NASDAQ:NKTR), and Gulfport Energy (NASDAQ:GPOR) were among the worst performers on the day. Here's why they did so poorly.

• [By Travis Hoium]

  The U.S. was once one of the most attractive markets for solar manufacturers, and a number of companies expanded into project development to increase their exposure here. For the past few years,�Canadian Solar�(NASDAQ:CSIQ)�has generated about one-third of its revenue in the Americas, the U.S. in particular.�But recent first-quarter results show that the U.S. isn't what it once was for the world's biggest manufacturers.�

• [By Travis Hoium]

  Solar stocks took a beating Monday after China cut its national incentives to install solar projects. Shares of solar panel manufacturers Canadian Solar Inc. (NASDAQ:CSIQ) fell as much as 14.5%, JinkoSolar Holding Co. (NYSE:JKS) dropped as much as 17%, and Daqo New Energy Corp (NYSE:DQ) fell as much as 31.3% while inverter manufacturer Enphase Energy Inc (NASDAQ:ENPH) fell up to 13.5%. By early afternoon, most major stocks in the solar industry were down double digits.

Why I Hired A Financial Planner - Even Though I'm A Financial Planner Myself

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1105478729&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1105478729/960x0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

In recent years, I&s;ve seen several articles about why hiring a financial planner could be beneficial, even for those in the financial planning profession.

My gut reaction to these articles was, that&s;s crazy talk. I love eating, breathing and dreaming about personal finance and no one cares about my finances more than me. Why would I shell out money on stuff I can do myself?

Recently, though, I had a change of heart. Here&s;s why my wife and I decided to hire a financial planner.

&l;span style=&q;text-decoration: underline;&q;&g;&l;strong&g;Our Reasons For Hiring A Financial Planner&l;/strong&g;&l;/span&g;

&l;strong&g;#1: To Receive Unbiased Third-Party Insight&l;/strong&g;

All of us are influenced, to some extent, by our &l;a href=&q;https://www.psychologytoday.com/us/blog/hidden-motives/201105/four-money-scripts?amp&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;money scripts&l;/a&g; &a;mdash; unconscious core beliefs about money that we&s;ve been developing since childhood. How we were raised and our relationship with money may influence, rightly or wrongly, our financial decisions. By working with an unbiased third party, my wife and I could ensure that past programming was not leading us to make bad decisions.

&l;strong&g;#2: To Level The Playing Field With My Wife&l;/strong&g;

I typically take charge of the family finances because of my interest and knowledge of the subject area. As a result, I&s;m often the one in our relationship who comes up with new ideas and &l;a href=&q;https://www.lifelaidout.com/blog/2017/2/16/about-the-mega-backdoor-roth-ira&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;strategies for our finances&l;/a&g;. While I run every major financial decision by my wife, she may not feel comfortable challenging or rejecting any of the strategies because she&s;s not as fluent in the topic.

&l;!--nextpage--&g;

Working with a financial planner allows both of us to be clients. For my wife, that means feeling more included in the process; and for me, that means, taking some of the pressure off of me while also gaining confirmation that our strategies are appropriate for our goals.

&l;strong&g;#3: To Avoid Blind Spots&l;/strong&g;

While I am a &l;a href=&q;https://www.lifelaidout.com/about/&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;financial planner&l;/a&g;, financial planning covers a variety of topic areas, including saving money, getting out of debt, managing human capital, developing investment strategies, and identifying insurance and estate planning needs, among others. I possess more knowledge and experience in some areas than others. Working with another planner ensures I&s;m not overlooking an important detail just because it&s;s not my strength.

&l;strong&g;#4: To Conduct Competitive Research&l;/strong&g;

Hiring my own financial planner gave me a firsthand look at how another planner does business and manages clients. In particular, I gained a sense of different approaches, timelines, styles and frequency of interaction, and even the type of language that can be used in communications. The experience allowed me to evaluate whether I could improve my existing processes in concrete ways.

&l;span style=&q;text-decoration: underline;&q;&g;&l;strong&g;How We Chose A Financial Planner&l;/strong&g;&l;/span&g;

We went through the same process for choosing a financial planner that I recommend to all of my readers, prospective clients, friends, and family (as outlined in this &l;a href=&q;https://www.forbes.com/sites/rogerma/2017/01/04/5-things-to-look-for-when-picking-a-financial-advisor/#3309d11f1fc4&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q;&g;prior article&l;/a&g;). Namely, we considered an advisor&s;s education and experience, certifications, fees and conflicts of interest, and desired working relationship.

We entered the search process with specific criteria.

From an education, experience, and certification perspective, we were looking for someone able to take a holistic look at our financial situation, which required expertise in general financial planning, taxes, and investments.

Being a &l;a href=&q;https://www.bogleheads.org/wiki/Getting_started&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;Boglehead&l;/a&g;, I also wanted to find a planner who believed in a similar investment philosophy. Specifically, my preferred approach focuses on capturing the market return through low-cost index funds and minimizing fees and taxes. Finally, because my wife and I were primarily looking for a second set of eyes, we wanted to find an advisor who offered a one-time project plan and charged flat fees rather than other service offerings, such as an ongoing retainer or an assets under management fee.

Based on these factors, we ultimately chose to work with &l;a href=&q;https://www.laminarwealth.com/&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;Laminar Wealth&l;/a&g; &a;mdash; which checked all the boxes we were looking for.

Overall, we were extremely pleased with the process. Hiring a financial planner helped confirm some of our instincts, provided us with suggestions we hadn&s;t considered previously, and allowed me to see into another planner&s;s processes. I came away with ideas on how to improve my personal financial situation, as well as my business. Talk about bang for the buck!&l;/p&g;